In the third episode of the series with Perry N. Halkitis, PhD, MS, MPH, he discusses how human behavior as well as other factors play a significant role in repeating outbreaks.
|Videos|March 28, 2019
Why Is the Opioid Overdose Death Rate Higher in People With HIV?
Author(s)Contagion® Editorial Staff
Karin Bosh, PhD, explains why the opioid overdose death rate was higher in 2015 than in 2011 among people with HIV.
Advertisement
Segment Description: Karin Bosh, PhD, a US Centers for Disease Control and Prevention epidemiologist in the Division of HIV/AIDS Prevention, explains why the opioid overdose death rate was higher in 2015 than in 2011 among people with HIV.
Interview transcript (modified slightly for readability):
Contagion®: Why might people diagnosed with HIV be more likely to die of an opioid overdose?
Dr. Bosh: "Previous research has found that persons with HIV are more likely to have chronic pain and they're also more likely to receive opioid analgesic treatments and receive higher doses of opioids. And in addition to that, persons with HIV are more likely to have substance abuse disorder and mental illness than the general population and all of these factors might contribute to why we see these higher rates."
The study, “
Advertisement
Related to this article
In the second episode of the series with Perry N. Halkitis, PhD, MS, MPH, he brings his personal experience to this topic and questions whether there should be a shift in who manages the primary care needs of these patients.
Here is a review of glucagon-like peptide-1 receptor agonist use in people with HIV.
In the first episode of our news series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates, and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
New gyrA testing guides ciprofloxacin use for gonorrhea, cutting ceftriaxone reliance while tackling resistance, access, and FDA hurdles.
Food expert Lynette Johnston, PhD, provides some context around the ongoing outbreak, discusses prevention, and compares 2026 food recalls with previous years.
The Peggy Lillis Foundation will host its 17th Annual Changing the Odds Gala this month in New York City, and it will include a casino, fellowship amongst the C diff community, and an award ceremony honoring a physician-scientist, philanthropist, a researcher, and a patient advocate for their contributions to C difficile awareness, treatment, and prevention.
Resistance-guided testing targeting a single gene mutation could let clinicians safely reintroduce ciprofloxacin for the majority of gonorrhea cases still susceptible to it, sparing ceftriaxone as resistance climbs worldwide. Lao-Tzu Allan-Blitz, MD, MPH, offers insights into his work in this area.
Advertisement
Advertisement